With 2024 well under way—and investors ready to go— a lingering question from 2023 remains: will small caps outperform in 2024? Boyar Research President Jonathan Boyar joins Yahoo Finance Live to weigh in on what investors should consider. Boyar encourages looking at “hidden assets”-small caps which appear to be the cheapest stocks in terms of valuation. For the retail investors, Boyar states that the process is not as complex as it may seem “its a case by case basis, there’s no magic formula. Its just doing your homework.” For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Eyek Ntekim
With 2024 well under way—and investors ready to go— a lingering question from 2023 remains: will small caps outperform in 2024?
Boyar Research President Jonathan Boyar joins Yahoo Finance Live to weigh in on what investors should consider. Boyar encourages looking at “hidden assets”-small caps which appear to be the cheapest stocks in terms of valuation.
For the retail investors, Boyar states that the process is not as complex as it may seem “its a case by case basis, there’s no magic formula. Its just doing your homework.”
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Editor's note: This article was written by Eyek Ntekim
The Wall Street Journal
Shares of QuantumScape are up about 50% Thursday after Volkswagen's battery subsidiary said lab tests of QuantumScape solid-state batteries showed [promising results](https://www.volkswagen-group.com/en/press-releases/powerco-confirms-results-quantumscapes-solid-state-cell-passes-first-endurance-test-18031).
The Wall Street Journal
Mobileye joined that club Thursday—in a particularly painful way. The maker of chips designed to power driver-assistance features warned investors that excess inventory at its customers will result in a drop in sales and earnings this year. Mobileye also projected adjusted operating income in the range of $270 million to $360 million, or less than half the $752 million that analysts had been expecting for the year, according to FactSet.
Barrons.com
Shares of Walgreens Boots Alliance fell by more than 10% after the pharmacy chain said it is cutting its quarterly dividend by nearly half. Walgreens shares initially jumped 2.4% in premarket trading following the announcement, but tumbled 11% as the regular session began. Adjusted earnings for the first quarter of Walgreens’ fiscal year, disclosed along with the news of the dividend cut, were 66 cents a share, beating the 62 cents a share consensus estimate among analysts tracked by FactSet, and down from $1.16 a share in the same quarter last year.
Read more --->